Results 161 to 170 of about 1,208,918 (256)
Pediatric Pulmonology, Volume 60, Issue 11, November 2025.
Andreas M. Matthaiou +3 more
wiley +1 more source
Current strategies for the long-term assessment, monitoring, and management of cystic fibrosis patients treated with CFTR modulator therapy [PDF]
J.S. Elborn +4 more
openalex +1 more source
P031 Perspectives for gene therapy with the use of CFTR modulators in patients with cystic fibrosis [PDF]
Luana da Silva Baptista Arpini +4 more
openalex +1 more source
Conflict of interest: No Introduction and Objectives: The impact of cystic fibrosis (CF) transmembrane conductance regulator (CFTR) modulators on the natural history of liver disease is unknown.
MANUEL MENDIZABAL +6 more
doaj +1 more source
Using a systems approach to identify the mechanism of action of correctors [PDF]
Tese de doutoramento, Biologia (Biologia de Sistemas), Universidade de Lisboa, Faculdade de Ciências, 2018Cystic Fibrosis (CF), the most common life-shortening genetic disorder among Caucasians, is caused by mutations in the gene encoding the Cystic ...
Awatade, Nikhil T
core
Chaperones as integrators of cellular networks: Changes of cellular integrity in stress and diseases
Cellular networks undergo rearrangements during stress and diseases. In un-stressed state the yeast protein-protein interaction network (interactome) is highly compact, and the centrally organized modules have a large overlap.
Albanese +54 more
core +2 more sources
176 Cystic fibrosis airway inflammation enhances the efficacy of CFTR modulators
Carla M. P. Ribeiro +7 more
openalex +1 more source
Profile of tezacaftor/ivacaftor combination and its potential in the treatment of cystic fibrosis
Dejene Shiferaw,* Shoaib Faruqi*Department of Respiratory Medicine, Hull University Teaching Hospitals NHS Trust, Cottingham HU16 5JQ, UK *These authors contributed equally to this workCorrespondence: Shoaib FaruqiDepartment of Respiratory Medicine ...
Shiferaw D, Faruqi S
doaj

